Member Info for miti1000

Added another 1k at 4500.

piljoe1212 ,

Thanks very much for that. For all the posts on savp in the past year , that was the only relevant or important one. If I had known that I'd not be be down 50k on my position.
Quite honestly, in future, I'll probably not touch a share where bondholders receive equity .It totally kills off the equity story if they are already in profit.
Lesson learned.
If the 7E deal goes thru , I'd imagine , the overhang will be cleared in short order .This does not remind of afren in that aspect as afren was a total con job.

For a bit more colour on Hive...

Consultancy Services - Hive Group
The Health Hive Group is a leading independent healthcare strategic consulting and communications business whose philosophy is to improve patient outcomes by creating change in healthcare communications.

About: The world of healthcare and communication is in constant flux and The Hive Group was founded to harness this evolution. The Group provides shared operations and talent vital to drive the growth of our companies and their clients. Hive operate globally for the majority of clients, but are currently centered out of London with 80 passionate health folk.

The Hive group has 3 operating companies:

Hive is a patient centric communication agency. Hive uses its understanding of patients and HCPs to influence and improve medicine engagement and experience.

ebee is a digital business with an emphasis on user behaviour. ebee uses a proprietary database to determine the digital behaviour profiles of the prescriber audience and respond to those behaviours with relevant digital interactions.

Pollen is a medical communications consultancy. Pollen develops scientific communication narratives that inform, motivate and empower target audiences to change what they think and what they do.

Healthcare part of strategic division ....why ?

35p to 24p I mean!!

pijoe1212 ,

Thanks for posting that but that doesn't tell us what the terms of the deal ie. at what cost price were the bondholders in for on the savp restructuring .That's the crux here . I'm imagining it was at a good profit otherwise they would be unlikely to dump the share from 25p to 24p or use hedging instruments to do so.

Its easy to pull out excerpts from a document without having clue at what it means to the bondholders intentions thereafter. That requires some real research which no one on here did or had a clue about.

The holding rns's to date indicate it wasn't any major shareholder so it has to be bondholder's imo .

I don;t buy the theory about worries over 7E closing otherwise we'd have seen major shareholders reducing .

Well , I don't often positions wrong but I have here . Holding 700k at 34p so not good and clearly a poor position.

The obvious lesson in future is to work out what the bondholders/convertible bond holders ( post equity raise restructuring) position might be. I think it may have been hard to do that based on the rns's but surely it was possible by digging into the 7E holders.

Too many posts for the past year have focussed on what savp have and the stunning assets but no one and I mean no one, has spent time on the bondholders costs or intentions with any foresight or research. That's been expensive for us all .35p tp 25p is some fall !! Anyway, lesson for the future perhaps.

I was waiting for a climatic bottom with volume before adding and I hope we might have had that on Friday. I'm not convinced the volume was enough to signify that but have added another 2 tranches of 37k at 25.20 a few mins ago.

The 7E completion is obviously a huge event .If that's done the volumes will be massive over 4/5 days and I assume will clear out the big sellers and then hopefully service will be resumed with normal buy/sell parameters applying.

Have listened to the conference call a few times in full . Everything very much on track and they've added some additional bullish stuff...such as Exon 14 news which looks really good and the likellihood for combinations .

We need the fruquintinib approval and I think we'll get to 70quid in short order .So much news in the pipeline .Ill just keep buying dips, if there are any.

Lily have 2 months after the Falluca to go for Fruq rights ex-china (global option). if they want to, then there follows 4 months of negotiation to agree a deal with hcm to exercise it.But hcm do not have to .So the longer Lily wait , the better for hcm imo.

I'd doubt that.
Lily can wait till after results of Falluca study . May cost them more but I think they won 't make a decision till Dec 2018 and then its about negotiation for a few months. By waiting, hcm will have stronger hand if the data is good.

Interesting close with a 12k buy at 50quid in the uk. Then low and behold a 3%rise in the US adr's . Results next Friday .Hope fully some good news on the way !!

Ah yes, fair enough davey , being a trader , I use it in a much shorter timerframe.
Btw, azn got Tagrisso approval in Canada for 1st line today.

Results on the 27th July.

As I said previously, the NDA approval won 't happen till late Q3 so its not imminent imo.

Zengas ,

It seems to be pretty clear that the reason SVp continues to langusigh well below the 35p placing price is the convertible bondholders selling in to the market. Any idea how long this continue for , if you agree that is ?
I had a conversataion with Andrew Knott at a meeting a few months ago and he was nonplussed at whom the sellers were as they get an updates shareholders list every week fwiw.

TIA.

Bought 1000 at 4100.

Bought 1000 at 4100.

Yes, I went to the presentation yesterday. Cornered AK before the meeting and asked him a few questions which I needed to know the answers to.He was quite forthcoming and impressive to talk to one on one..Needless, to say, all on track and I'll be buying more.

Anyone going to Knott's presentation today ? I think I will.

1.5million trade gone thru at 32p